Literature DB >> 11982597

IgA autoreactivity: a feature common to inflammatory bowel and connective tissue diseases.

L Kazemi-Shirazi1, C H Gasche, S Natter, A Gangl, J Smolen, S Spitzauer, P Valent, D Kraft, R Valenta.   

Abstract

The immunopathogenic mechanisms in inflammatory bowel disease (IBD) are not yet fully established. The aim of this study was to determine the profile and magnitude of IgA and IgG autoantibodies in IBD patients. The autoantigen profile defined by IgA and IgG antibodies from 24 IBD (14 Crohn's disease CD], 10 ulcerative colitis UC]), three coeliac, 12 connective tissue disease (CTD) patients and 10 healthy individuals was studied in human cellular extracts by Western blotting. The magnitude of the IgA and IgG1-4 subclass responses was measured by ELISA. IBD patients could not be distinguished from healthy individuals on the basis of IgG autoantibodies to Western blotted proteins. IgG subclass analysis indicated no clear bias towards Th1 or Th2 immune responses in IBD or CTD. In accordance with previous work, we found that IgA autoreactivity was strongest in coeliac disease patients. Unexpectedly, IBD as well as CTD patients exhibited strong IgA autoantibody reactivities to components of similar molecular weights (16-80 kD) in intestinal and non-intestinal epithelial cell lines. Our data indicate immunopathogenic similarities between IBD and CTD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11982597      PMCID: PMC1906379          DOI: 10.1046/j.1365-2249.2002.01804.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

Review 1.  Autoantibodies in pathology and cell biology.

Authors:  E M Tan
Journal:  Cell       Date:  1991-11-29       Impact factor: 41.582

2.  Classification of inflammatory bowel disease.

Authors:  J E Lennard-Jones
Journal:  Scand J Gastroenterol Suppl       Date:  1989

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Alterations of IgM, IgG, and IgA Synthesis and secretion by peripheral blood and intestinal mononuclear cells from patients with ulcerative colitis and Crohn's disease.

Authors:  R P MacDermott; G S Nash; M J Bertovich; M V Seiden; M J Bragdon; M G Beale
Journal:  Gastroenterology       Date:  1981-11       Impact factor: 22.682

5.  Antibodies to cytoskeletal proteins in patients with Crohn's disease.

Authors:  W J Mayet; A G Press; E Hermann; R Moll; M Manns; K Ewe; K H Meyer zum Büschenfelde
Journal:  Eur J Clin Invest       Date:  1990-10       Impact factor: 4.686

6.  Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.

Authors:  D Rachmilewitz
Journal:  BMJ       Date:  1989-01-14

7.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

Authors:  W R Best; J M Becktel; J W Singleton; F Kern
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

8.  A shared and unique peptide in the human colon, eye, and joint detected by a monoclonal antibody.

Authors:  S Bhagat; K M Das
Journal:  Gastroenterology       Date:  1994-07       Impact factor: 22.682

Review 9.  Arthritic manifestations of inflammatory bowel disease.

Authors:  E M Gravallese; F G Kantrowitz
Journal:  Am J Gastroenterol       Date:  1988-07       Impact factor: 10.864

10.  Peptide and protein molecular weight determination by electrophoresis using a high-molarity tris buffer system without urea.

Authors:  S P Fling; D S Gregerson
Journal:  Anal Biochem       Date:  1986-05-15       Impact factor: 3.365

View more
  8 in total

1.  Microbial Translocation and B Cell Dysfunction in Human Immunodeficiency Virus Disease.

Authors:  Wei Jiang
Journal:  Am J Immunol       Date:  2012

2.  Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn disease.

Authors:  Timothy S Olson; Giorgos Bamias; Makoto Naganuma; Jesús Rivera-Nieves; Tracy L Burcin; William Ross; Margaret A Morris; Theresa T Pizarro; Peter B Ernst; Fabio Cominelli; Klaus Ley
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

3.  Altered Systemic and Intestinal IgA Immune Responses in Individuals With Type 1 Diabetes.

Authors:  Juan Huang; Gan Huang; Xia Li; Fang Hu; Zhiguo Xie; Yang Xiao; Shuoming Luo; Chen Chao; Keyu Guo; F Susan Wong; Zhiguang Zhou; Li Wen
Journal:  J Clin Endocrinol Metab       Date:  2020-12-01       Impact factor: 5.958

4.  SHIP deficiency causes Crohn's disease-like ileitis.

Authors:  William G Kerr; Mi-Young Park; Monique Maubert; Robert W Engelman
Journal:  Gut       Date:  2010-10-12       Impact factor: 23.059

5.  The primary defect in experimental ileitis originates from a nonhematopoietic source.

Authors:  Timothy S Olson; Brian K Reuter; Kevin G-E Scott; Margaret A Morris; Xiao-Ming Wang; Leslie N Hancock; Tracy L Burcin; Steven M Cohn; Peter B Ernst; Fabio Cominelli; Jonathan B Meddings; Klaus Ley; Theresa T Pizarro
Journal:  J Exp Med       Date:  2006-02-27       Impact factor: 14.307

6.  Microbial TLR Agonists and Humoral Immunopathogenesis in HIV Disease.

Authors:  Xiaocong Yu; Zihai Li; Zhenxian Zhou; J Michael Kilby; Wei Jiang
Journal:  Epidemiology (Sunnyvale)       Date:  2013-02-02

Review 7.  Mechanisms of Microbe-Host Interaction in Crohn's Disease: Dysbiosis vs. Pathobiont Selection.

Authors:  Ludovica F Buttó; Monika Schaubeck; Dirk Haller
Journal:  Front Immunol       Date:  2015-11-19       Impact factor: 7.561

8.  Apoptosis in response to microbial infection induces autoreactive TH17 cells.

Authors:  Laura Campisi; Gaetan Barbet; Yi Ding; Enric Esplugues; Richard A Flavell; J Magarian Blander
Journal:  Nat Immunol       Date:  2016-07-25       Impact factor: 31.250

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.